You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Seasonal Coronavirus

Showing 1 - 25 of 2,824
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ImmuneSense™ COVID-19 Cross-Reactivity Study

Suspended
  • Coronavirus Disease
  • SARS-CoV-2 Infection
    • Seattle, Washington
      Adaptive Biotechnologies
    Aug 3, 2022

    Covid19 Trial (complication)

    Not yet recruiting
    • Covid19
    • complication
    • (no location specified)
    Jun 13, 2022

    SARS-CoV-2 Infection, COVID-19 Trial in United Kingdom (SARS-CoV-2 rS/Matrix M1-Adjuvant, Placebo, Licensed seasonal influenza

    Active, not recruiting
    • SARS-CoV-2 Infection
    • COVID-19
    • SARS-CoV-2 rS/Matrix M1-Adjuvant
    • +2 more
    • Belfast, Antrim, United Kingdom
    • +32 more
    Oct 19, 2022

    Prognostic Value of IgM in Covid-19 Infection

    Not yet recruiting
    • COVID-19
      • (no location specified)
      Apr 4, 2022

      Seasonal Factors and COVID 19

      Completed
      • COVID-19 Pandemic
      • Polymerase chain reaction
      • İzmir, Turkey
        IKCU, Atatürk Eğitim ve Araştırma Hastanesi, Acil Tıp
      Mar 1, 2022

      Epidemiological Outbreak of SARS-CoV-2 Pandemic

      Active, not recruiting
      • COVID-19
        • Galdakao, Bizkaia, Spain
          Hospital Galdakao-Usansolo
        Oct 9, 2023

        Coronavirus Infection, COVID Trial in Adelaide (COVID19 vaccine, Saline)

        Completed
        • Coronavirus Infection
        • COVID
        • COVID19 vaccine
        • Saline
        • Adelaide, South Australia, Australia
          PARC,
        Feb 12, 2022

        COVID-19 Vaccination in Overweight People With Excessive BMI

        Recruiting
        • Covid19
        • Overweight
        • SARS-COV-2 VACCINE
        • Chongqing, China
          China
        Sep 10, 2021

        COVID-19 Symptom Tracker

        Recruiting
        • COVID-19
        • No Intervention
        • Boston, Massachusetts
        • +1 more
        Mar 30, 2022

        Covid-19 Trial in Falls Church (Convalescent plasma transfusion)

        Terminated
        Has Results
        • Covid-19
        • Convalescent plasma transfusion
        • Falls Church, Virginia
          Inova Fairfax Medical Campus
        Jan 5, 2022

        Pulmonary Alveolar Proteinosis, COPD, Idiopathic Pulmonary Fibrosis Trial in Stevensville (procedure, device, drug)

        Enrolling by invitation
        • Pulmonary Alveolar Proteinosis
        • +5 more
        • Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF)
        • +4 more
        • Stevensville, Montana
          Robert W. Alexander, MD, FICS, LLC
        Mar 4, 2022

        COVID-19 Vaccination in Patients With Chronic Liver Diseases

        Recruiting
        • Liver Diseases
        • +2 more
        • SARS-COV-2 VACCINE
        • Chongqing, Chongqing, China
          The second affiliated Hospital of Chongqing Medical University
        Aug 12, 2021

        Immune Response, Safety Trial in Incheon (bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza

        Active, not recruiting
        • Immune Response
        • Safety
        • bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
        • quadrivalent influenza vaccine
        • Incheon, Seo-gu, Korea, Republic of
          International St. Mary's hospital
        Jul 28, 2023

        COVID-19 Trial in Russian Federation (AZD1222)

        Withdrawn
        • COVID-19
        • AZD1222
        • Moscow, Russian Federation
        • +3 more
        Sep 27, 2021

        Acute Respiratory Infection Using a Mobile-Based Study Platform

        Completed
        • Covid19
        • +4 more
          • Boston, Massachusetts
            Boston Children's Hospital
          Mar 4, 2022

          SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

          Completed
          • SARS-CoV-2 Infection
          • COVID-19
          • BNT162b2
          • +2 more
          • Brookvale, New South Wales, Australia
          • +25 more
          Nov 13, 2023

          Immunity to Infection in Healthy Participants and Cancer

          Recruiting
          • Influenza
          • +3 more
          • Biological sample collection
          • Tuebingen, Baden-Wuerttemberg, Germany
            University Hopsital Tuebingen
          Mar 31, 2023

          Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2

          Recruiting
          • Influenza
          • COVID-19
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Dec 13, 2022

            Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Lausanne (LD Vehicle-GNP, LD PepGNP-SARSCoV2, HD Vehicle-GNP)

            Completed
            • Coronavirus
            • +2 more
            • LD Vehicle-GNP
            • +3 more
            • Lausanne, Vaud, Switzerland
              Center for Primary Care and Public Health (Unisante)
            Nov 28, 2022

            SARS-CoV-2, Seasonal Influenza, Respiratory Syncytial Virus Trial in United States (mRNA-1273, mRNA-1010, mRNA-1345)

            Recruiting
            • SARS-CoV-2
            • +3 more
            • mRNA-1273
            • +4 more
            • Hollywood, Florida
            • +7 more
            May 25, 2022

            COVID-19 Trial in Chicago (Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo)

            Active, not recruiting
            • COVID-19
            • Experimental: Primary Cohort
            • Placebo Comparator: Primary Cohort - Placebo
            • Chicago, Illinois
              University of Chicago
            Aug 24, 2023

            The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection

            Recruiting
            • SARS-CoV-2
            • Covid 19
            • NRICM101
            • Taipei, Taiwan
              National Research Institute of Chinese Medicine, Ministry of Hea
            Jan 11, 2021

            Immunity, Vaccine Reaction, Influenza Trial in Barcelona (ABBC1 Immunoessential, Placebo)

            Completed
            • Immunity
            • +5 more
            • ABBC1 Immunoessential
            • Placebo
            • Barcelona, Spain
              Hospital Mare de Déu de la Mercè - Germanes Hospitalàries
            Jul 19, 2022

            Convalescent Plasma for COVID 19 Trial in Saudi Arabia (convalescent plasma from recovered COVID 19 donor)

            Completed
            • Convalescent Plasma for COVID 19
            • convalescent plasma from recovered COVID 19 donor
            • Dhahran, Eastern Provence, Saudi Arabia
            • +13 more
            Nov 14, 2021

            National Vaccine Adverse Event Reporting Survey and Etiology

            Recruiting
            • COVID-19
            • +12 more
            • vaccinated
            • Northglenn, Colorado
              Neuroganics LLC
            Mar 3, 2022